Xcopri 150 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F1LYJ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,801
Award facts
- Contract value 100% obligated
- $1,801.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,801.47 on December 18, 2025, for the supply of Xcopri 150 mg tablets (30-count packaging). This is a firm fixed-price delivery order with an ultimate completion date of December 19, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply vehicle for military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, maintains a significant role in federal medical procurement through its DLA IDC. The company supplies a broad range of pharmaceutical products and medical supplies to support military and veteran healthcare systems, including brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. Xcopri, an antiepileptic medication, aligns with AmerisourceBergen's typical product portfolio supporting the Defense Health Agency and other federal healthcare customers. The DLA Troop Support is planning to establish generation V pharmaceutical prime vendor contracts with multiple regional awards anticipated in the coming years, positioning AmerisourceBergen among key vendors supporting global military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F1LYJ?
SPE2DR26F1LYJ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26F1LYJ worth?
The government has obligated $1,801 on SPE2DR26F1LYJ.
Is contract SPE2DR26F1LYJ an order under another contract?
Yes. SPE2DR26F1LYJ is a delivery order under SPE2DR25D2215, an indefinite delivery contract.
Was contract SPE2DR26F1LYJ competed?
The extent of competition for SPE2DR26F1LYJ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award